Publications

Probity Medical Research has compiled journals, articles and presentations for your personal review. Please use the search features below to find an article.

 

If you would like to request an article for personal review please complete the registration form. These publications are for personal use only and cannot be distributed. 

Register

 

Already granted access to an article?  

Login

 

If you cannot find the article you are looking for please contact Probity Medical Research. 

Journals, Articles and Presentations

Found 38 matches.
Page:
4
Refine your search to narrow the results.

Major Adverse Cardiovascular Events (MACE) Among New Users of Biologic Therapies in The Psoriasis Longitudinal Assessment and Registry (PSOLAR) Study

Presented at European Academy of Dermatology & Venereology (EADV), Istanbul, Turkey, October 2-6, 2013

Condition
Psoriasis
Author
R. Bissonnette, A.B. Gottlieb, F. Kerdel, L. Naldi, K. Papp, S. Calabro, W. Langholff, M. Chevrier, S. Fakharzadeh, on behalf of the PSOLAR Steering Committee
Year
2013
Register & Request Access

Apremilast, an Oral Phosphodiesterase 4 Inhibitor in Nail and Scalp Psoriasis 52-Week Results From the Esteem 1 Study

Presented at European Academy of Dermatology & Venereology (EADV), Istanbul, Turkey, October 2-6, 2013

Condition
Psoriasis
Author
K. Papp, K. Reich, C. Leonardi, L. Kircik, S. Chimenti, P. Rich, C. Hu, R.M. Stevens, R.M. Day, C.E.M. Griffiths
Year
2013
Register & Request Access

Effects of Apremilast on Health-Related Quality of Life in Patients With Moderate to Severe Plaque Psoriasis: Results From the Esteem 1 Study

Presented at European Academy of Dermatology & Venereology (EADV), Istanbul, Turkey, October 2-6, 2013

Condition
Psoriasis
Author
Kristian Reich, Kim Papp, Craig Leonardi, Leon Kircik, Sergio Chimenti, ChiaChi Hu, Randall M. Stevens, Robert M. Day, Christopher E.M. Griffiths
Year
2013
Register & Request Access

Etanercept Plus Topical Therapies: Results from the REFINE Study

Presented at the Fall Clinical Dermatology Conference, Las Vegas, Nevada, October 17-20, 2013

Condition
Psoriasis
Author
Kim A. Papp, Kirk Barber, Robert Bissonnette, Marc Bourcier, Charles W. Lynde, Yves Poulin, Jennifer Shelton, Jack Toole, Andrew Vieira, Melanie Poulin-Costello
Year
2013
Register & Request Access

Preparing for Subsequent Entry Biologics in Dermatology and Rheumatology in Canada

Journal of Cutaneous Medicine and Surgery 2013 Oct 1;17(5):340-346.

Journal
Journal of Cutaneous Medicine and Surgery (JCMS)
PubMed ID
24067855
Condition
Biologics
Author
Kim Papp, Marc Bourcier, Vincent Ho, Karen Burke, and Boulos Haraoui
Year
2013
Register & Request Access

Study Design and Baseline Characteristics from a Phase 3, Randomized, Double-Blind Study of Adalimumab versus Methotrexate Treatment in Pediatric Patients with Chronic Plaque Psoriasis

Presented at the 4th Congress of the Psoriasis International Network, Paris, France, July 4-6, 2013

Condition
Pediatric Psoriasis
Author
Kim Papp, Diamant Thaci, Ian Landells, Kristina Unnebrink, David A. Williams
Year
2013
Register & Request Access

Small Molecules: An Overview of Emerging Therapeutic Options in the Treatment of Psoriasis

Skin Therapy Letter 2013 Nov-Dec;18(7):1-4.

Journal
Skin Therapy Letter
Condition
Psoriasis
Author
Melinda Gooderham
Year
2013
Register & Request Access

Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics

Journal of American Academy of Dermatology 2013 Nov;69(5):729-35. doi: 10.1016/j.jaad.2013.07.023. Epub 2013 Aug 24.

Journal
Journal of American Acadamy of Dermatology (JAAD)
PubMed ID
23981683
Condition
Psoriatic Arthritis
Author
Philip J. Mease, Dafna D. Gladman, Kim A. Papp, Majed M. Khraishi, Diamant Thaci, Frank Behrens, Robert Northington, Joanne Fuiman, Eustratios Bananis, Robert Boggs, and Daniel Alvarez
Year
2013
Register & Request Access
Page:
4

Copyright 2014 Probity Medical Research Inc. All Rights Reserved.

Login